Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
SRPT earnings call for the period ending December 31, 2023.
Source: yahoo.com
Stay updated with breaking news from Gena Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SRPT earnings call for the period ending December 31, 2023.
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
BCRX earnings call for the period ending December 31, 2023.
Operator: Good day, and thank you for standing by. Welcome to the Moderna Fourth Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.